An Evidence-Based Review of Galcanezumab for the Treatment of Migraine.
Urits I, Yilmaz M, Charipova K, Gress K, Bahrum E, Swett M, Berger AA, Kassem H, Ngo AL, Cornett EM, Kaye AD, Viswanath O.
Urits I, et al. Among authors: viswanath o.
Neurol Ther. 2020 Dec;9(2):403-417. doi: 10.1007/s40120-020-00214-3. Epub 2020 Oct 3.
Neurol Ther. 2020.
PMID: 33010021
Free PMC article.
Review.